• 1
    Ferrell L, Wright T, Roberts J, Ascher N, Lake J. Hepatitis C viral infection in liver transplant recipients. Hepatology 1992; 16: 865876.
  • 2
    Feray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, Reynes M, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995; 108: 10881096.
  • 3
    Gretch DR, Bacchi CE, Corey L, Dela Rosa C, Lesniewski RR, Kowdley K, Gown A, et al. Persistent hepatitis C virus infection after liver transplantation: clinical and virological features. Hepatology 1995; 22: 19.
  • 4
    Schulger L, Sheiner P, Min A, Wolf D, Fiel I, Thang SN, Zhang D, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. AASLD Viral Hepatitis and Liver Transplantation, Reston VA, 1995.
  • 5
    Zein N, Rakela J, Poterucha J, Steers JL, Wiesner RH, Persing DH. HCV genotypes in liver transplant recipients: Distribution and 1-year follow-up. Liv Transpl Surg 1995; 1: 354357.
  • 6
    Gane EJ, Naoumov NK, Qian KP, Mondelli MU, Maertens G, Portmann BC, Lau JYM, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996; 110: 167177.
  • 7
    Dusheiko G, Schmilovitz-Weiss H, Brown D, McOmish F, Yap P, Sherlock S, McLntyre N, et al. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 1994; 19: 138.
  • 8
    Nousbaum J, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C, and The Collaborative Study Group. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995; 122: 161168.
  • 9
    Tsubota A, Chayarna K, Ikeda K, Yasuji A, Koida I, Saitoh S, Hashimoto M, et al. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology 1994; 19: 10881094.
  • 10
    Bacon BR, Farrell G, Benhamou JP, Hopf U, Barcena R, Feinman SV, Rizzetto M, et al. Lymphoblastoid interferon improves long-term response to a six month course of treatment when compared with recombinant interferon alfa 2b: Results of an international trial [Abstract]. Hepatology 1995; 22: 152A.
  • 11
    Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237238.
  • 12
    Wright T, Hsu H, Donegan E, Feinstone S, Greenberg H, Read A, Ascher NL, et al. Hepatitis C virus not found in fulminant non-A, non-B hepatitis. Ann Intern Med 1991; 115: 111112.
  • 13
    Chazouilleres O, Kim M, Combs C, Ferrell L, Bacchetti P, Roberts J, Ascher NL, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994; 106: 9949.
  • 14
    Lau JYN, Simmonds P, Urdea MS. Implications of variations of “conserved” regions of hepatitis C virus genome. Lancet 1995; 346: 425426.
  • 15
    Simmonds P, Alberti A, Alter H, Bonino F, Bradely DW, Brechot C, Brouwer JT, et al. A proposed system for the nomenclature of hepatitis C virus genotypes. Hepatology 1994; 19: 13211324.
  • 16
    Chayama K, Tsubota A, Saitoh S, Koida I, Ikeda K, Matsumoto T, Kobayashi M, et al. Genotypic subtyping of hepatitis C virus. J Gastroenterol and Hepatol 1993; 8: 150156.
  • 17
    Okamoto H, Sugiyama Y, Okada S, Kurai K, Sugai Y, Tanaka T, Sato K, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 673679.
  • 18
    Lau JYN, Mizokami M, Kolberg J, Davis GL, Prescott LE, Ohno T, Perrillo RP, et al. Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis 1995; 171: 28189.
  • 19
    Davidson F, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, Follett EA, Seed CR, et al. Survey of major genotypes and subtypes of hepatitis C using RFLP of sequences amplified from the 5′ non-coding region. J Gen Virol 1995; 76: 11971204.
  • 20
    Simmonds P, Rose K, Graham S, Chan SW, McOmish F, Dow BC, Follett EAC, et al. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J Clin Microbiol 1993; 31: 14931503.
  • 21
    Mahaney K, Tedeschi V, Maertens G, Di Bisceglie A, Vergalla J, Hoofnagle JH, Sallie R. Genotypic analysis of hepatitis C virus in American patients. Hepatology 1994; 20: 14051411.
  • 22
    Widell A, Shev S, Mansson S, Zhang YY, Foberg U, Norkrnas G, Fryden A, et al. Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: epidemiological applications. J Med Virol 1994; 44: 272279.
  • 23
    Hsu H, Wright T, Tsao S, Combs C, Donets M, Feinstone SM, Greenberg HB. Antibody response to hepatitis C virus infection after liver transplantation. Am J Gastroenterol 1994; 89: 11691174.
  • 24
    Belli L, Silini E, Alberti A, Bellati G, Fesce E, Gelosa F, Asti L, et al. HCV genotypes, post transplant hepatitis (PTH) and HCV recurrence after liver transplantation (Abstract). Hepatology 1994; 204(pt 2): 131A.